Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
5.73B | 5.68B | 5.27B | 5.12B | 4.92B | 4.13B | Gross Profit |
3.19B | 3.16B | 2.93B | 2.94B | 2.94B | 2.39B | EBIT |
1.05B | 1.04B | 933.60M | 1.06B | 1.14B | 676.60M | EBITDA |
1.74B | 1.72B | 1.58B | 1.67B | 1.58B | 1.22B | Net Income Common Stockholders |
612.30M | 604.10M | 545.30M | 696.20M | 744.20M | 520.10M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
201.00M | 169.90M | 216.80M | 285.20M | 224.70M | 1.68B | Total Assets |
12.25B | 11.76B | 12.28B | 11.55B | 11.04B | 9.61B | Total Debt |
5.63B | 5.01B | 5.71B | 5.79B | 5.29B | 4.38B | Net Debt |
5.42B | 4.84B | 5.49B | 5.50B | 5.07B | 2.69B | Total Liabilities |
7.54B | 6.84B | 7.59B | 7.57B | 7.44B | 6.40B | Stockholders Equity |
4.56B | 4.80B | 4.53B | 3.96B | 3.58B | 3.17B |
Cash Flow | Free Cash Flow | ||||
808.90M | 813.00M | 515.50M | 132.60M | 865.80M | 524.90M | Operating Cash Flow |
1.30B | 1.32B | 1.12B | 757.10M | 1.33B | 946.20M | Investing Cash Flow |
-486.80M | -511.50M | -878.20M | -959.50M | -3.40B | -492.70M | Financing Cash Flow |
-810.30M | -846.40M | -306.20M | 273.70M | 628.90M | 810.80M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $43.89B | 45.95 | 475.86% | 0.52% | 7.20% | 27.36% | |
73 Outperform | $32.56B | 53.54 | 12.83% | 0.59% | 7.12% | 9.05% | |
72 Outperform | $16.23B | 44.55 | 8.68% | 0.51% | 8.85% | ― | |
64 Neutral | $4.39B | 11.81 | 5.20% | 249.38% | 3.96% | -12.36% |
On May 8, 2025, Equifax held its Annual Meeting of Shareholders, where several key decisions were made. Shareholders elected ten directors, approved executive compensation, ratified Ernst & Young LLP as the independent accounting firm, and eliminated supermajority voting requirements in the company’s Articles of Incorporation.